56 studies found for:    " September 09, 2009":" October 09, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed
Has Results
Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth
Conditions: HIV Infections;   H1N1 Influenza Virus
Intervention: Biological: Influenza A (H1N1) 2009 monovalent vaccine
22 Completed Pilot Study to Compare the Pharmacokinetics Parameters in Plasma and Intracellular of Raltegravir Administered Once a Day in Adult Patients Infected With HIV
Condition: HIV Infections
Intervention: Drug: Raltegravir
23 Completed Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women
Conditions: Malaria;   HIV Infections
Interventions: Drug: Lopinavir/ritonavir;   Drug: Efavirenz;   Drug: Zidovudine;   Drug: Lamivudine
24 Completed Pharmacokinetics of Lamivudine at Two Different Doses
Condition: HIV Infections
Intervention: Drug: Lamivudine (3TC)
25 Completed
Has Results
Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir
Condition: HIV Infection
Interventions: Biological: DNA + HIV-rAd5 vaccine;   Drug: ART intensification (raltegravir);   Drug: ART intensification (maraviroc)
26 Terminated
Has Results
Effect of Rosuvastatin on Endothelial Function
Conditions: HIV Infections;   Cardiovascular Disease
Intervention: Drug: rosuvastatin
27 Completed Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected Patients
Conditions: HIV Infections;   Lipoatrophy
Interventions: Drug: EFV;   Drug: LPV/r
28 Completed
Has Results
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
Conditions: HIV Infection;   Hepatitis C Infection
Interventions: Drug: Nitazoxanide (NTZ);   Drug: Pegylated interferon alfa-2a (PEG);   Drug: Ribavirin (RBV)
29 Completed Mothers Living With HIV and Their Adolescent Children
Conditions: Family Relations;   Mental Health;   Physical Health;   Risky Sexual Behavior;   Substance Use;   HIV Infections
Intervention: Behavioral: Cognitive-behavioral, small-group format sessions
30 Completed QoL and Adherence to One-pill Once-a-day HAART
Conditions: HIV Infection;   HIV Infections
Intervention: Other: reduced number of pills
31 Completed Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis
Conditions: Cryptococcal Meningitis;   HIV Infections
Intervention: Other: Early antiretroviral therapy
32 Unknown  The Effect of Combination of Traditional Chinese Medicine (TCM) and Highly Active Antiretroviral Therapy (HAART) on Immune Reconstitution of HIV/AIDS Patients
Conditions: Acquired Immune Deficiency Syndrome Virus;   HIV Infections
Interventions: Drug: Fuzheng 3;   Drug: Fuzheng 1;   Drug: Placebo
33 Unknown  Research on Effect of Traditional Chinese Medicine (TCM) on Immune Reconstitution of HIV/AIDS Patients After Highly Active Antiretroviral Therapy (HAART)
Conditions: Acquired Immune Deficiency Syndrome Virus;   HIV Infections
Interventions: Drug: Fuzheng 2;   Drug: Placebo
34 Unknown  Clinical Trials on the Effect of Immunity 1 (Fuzheng 1) on Immune Reconstitution of HIV Patients
Conditions: Acquired Immune Deficiency Syndrome Virus;   HIV Infections
Interventions: Drug: Fuzheng 1;   Drug: Placebo
35 Completed
Has Results
Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol Levels
Conditions: HIV Infections;   Dyslipidemia;   Endothelial Dysfunction
Intervention: Drug: extended release niacin
36 Completed
Has Results
Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1
Conditions: HIV-1 Infection;   HIV Infections
Interventions: Drug: maraviroc;   Drug: darunavir;   Drug: ritonavir
37 Completed
Has Results
Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses.
Condition: Acquired Immunodeficiency Syndrome
Intervention: Drug: lopinavir/ritonavir
38 Completed Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection (PHI-IMD).
Condition: HIV
Interventions: Drug: HAART;   Drug: HAART + Immunotherapy
39 Completed
Has Results
Cardiovascular Prevention for Persons With HIV
Conditions: HIV Infection;   Cardiovascular Disease Risk
Interventions: Drug: Pravastatin;   Drug: Lisinopril
40 No longer available A Treatment Access Program To Provide Maraviroc To Eligible Adult Patients Completing A4001050 Study Until Commercial Availability Of Maraviroc (Celsentri) In India
Condition: Human Immunodeficiency Virus (HIV)
Intervention: Drug: Open Label Treatment Access: Maraviroc

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-56) Show next page of results    Last Page
Indicates status has not been verified in more than two years